PHASE-I STUDY - CLOPIDOGREL - A PLATELET INHIBITOR WHICH INHIBITS THROMBOGENESIS IN HUMAN NONANTICOAGULATED BLOOD INDEPENDENTLY OF THE BLOOD-FLOW CONDITIONS
He. Roald et al., PHASE-I STUDY - CLOPIDOGREL - A PLATELET INHIBITOR WHICH INHIBITS THROMBOGENESIS IN HUMAN NONANTICOAGULATED BLOOD INDEPENDENTLY OF THE BLOOD-FLOW CONDITIONS, Thrombosis and haemostasis, 69(6), 1993, pp. 1240-1240